NCT00708578View on ClinicalTrials.gov

Optimal Oral Hypoglycaemic Agents (OHA) for Combination With Insulin Glargine (Sulfonylurea vs. Metformin)

PHASE4CompletedINTERVENTIONAL
Enrollment

99

Participants

Timeline

Start Date

May 31, 2008

Primary Completion Date

December 31, 2009

Study Completion Date

December 31, 2009

Conditions
Type 2 Diabetes Mellitus
Interventions
DRUG

Glimepiride

Once a day before breakfast

DRUG

Metformin

After breakfast and supper

DRUG

Insulin Glargine

Injection in the morning

Trial Locations (1)

Unknown

Sanofi-Aventis Administrative Office, Seoul

Sponsors

Lead Sponsor

Sanofi
All Listed Sponsors
lead

Sanofi

INDUSTRY

NCT00708578 - Optimal Oral Hypoglycaemic Agents (OHA) for Combination With Insulin Glargine (Sulfonylurea vs. Metformin) | Biotech Hunter | Biotech Hunter